Goldman Sachs’s Maze Therapeutics, Inc. Common Stock MAZE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-13,129
Closed -$145K 5448
2025
Q1
$145K Buy
+13,129
New +$145K ﹤0.01% 4748